Exagen XGN

$ 5.01 6.3%

Quarterly report 2024-Q3
added 11-12-2024

Exagen Balance Sheet 2011-2024 | XGN

Annual Balance Sheet Exagen

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-16.3 M	-32.6 M	-72 M	-4.13 M	-46 M	11.5 M	7.6 M	-	23.4 M	13.9 M	1.17 M	-150 K	-
Long Term Debt	19.2 M	28.8 M	27.5 M	26.7 M	25.9 M	24.6 M	18.8 M	-	-	-	-	1.38 M	-
Long Term Debt Current	976 K	1.04 M	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	27.8 M	26.8 M	26.7 M	20 M	-	1.89 M	4.94 M	5.42 M	4.05 M	-
Total Current Liabilities	11.9 M	9.62 M	9.32 M	8.77 M	5.9 M	-	-	-	-	-	-	-	-
Total Liabilities	34.2 M	43.8 M	38.5 M	36.5 M	32.7 M	35.6 M	25 M	-	36.8 M	31.2 M	16 M	6.44 M	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-279 M	-256 M	-208 M	-181 M	-165 M	-153 M	-148 M	-	-108 M	-89.3 M	-74.3 M	-60.8 M	-
Total Assets	56.9 M	86.2 M	123 M	78.4 M	88.3 M	28.9 M	20.4 M	-	14.6 M	17.1 M	16.5 M	11.3 M	-
Cash and Cash Equivalents	36.5 M	62.4 M	99.4 M	57.4 M	72.1 M	13.3 M	-	-	-	-	-	-	-
Book Value	22.7 M	42.5 M	84.9 M	41.8 M	55.7 M	-6.73 M	-4.64 M	-	-22.2 M	-14.1 M	451 K	4.82 M	-
Total Shareholders Equity	22.7 M	42.5 M	84.9 M	41.8 M	55.7 M	-112 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Exagen

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	19.8 M	19.8 M	19.3 M	19.2 M	19.2 M	19.2 M	29.1 M	28.8 M	28 M	-	27.7 M	27.5 M	27.3 M	27.1 M	26.9 M	26.7 M	26.7 M	26.7 M	26.7 M	25.9 M	25.9 M	25.9 M	25.9 M	24.6 M	24.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	30.7 M	31.7 M	30.8 M	34.2 M	33.4 M	32.3 M	43.3 M	43.8 M	45.4 M	44 M	45.9 M	38.5 M	37 M	36.9 M	36.1 M	36.5 M	36.5 M	36.5 M	36.5 M	32.7 M	32.7 M	32.7 M	32.7 M	35.6 M	35.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-291 M	-286 M	-283 M	-279 M	-274 M	-268 M	-263 M	-256 M	-241 M	-233 M	-218 M	-208 M	-201 M	-194 M	-187 M	-181 M	-181 M	-181 M	-181 M	-165 M	-165 M	-165 M	-165 M	-153 M	-153 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	43.6 M	49.3 M	50.8 M	56.9 M	60.9 M	64.2 M	79.2 M	86.2 M	102 M	107 M	122 M	123 M	128 M	133 M	138 M	78.4 M	78.4 M	78.4 M	78.4 M	88.3 M	88.3 M	88.3 M	88.3 M	28.9 M	28.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	22 M	24.5 M	27.3 M	36.5 M	28.6 M	31.7 M	52.4 M	62.4 M	68.9 M	76.5 M	89.8 M	99.4 M	107 M	113 M	118 M	57.4 M	57.4 M	57.4 M	57.4 M	72.1 M	72.1 M	72.1 M	72.1 M	13.2 M	13.2 M	-	-	11.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	12.9 M	17.6 M	20 M	22.7 M	27.5 M	31.9 M	35.9 M	42.5 M	56.2 M	62.8 M	76.2 M	84.9 M	90.8 M	96.4 M	101 M	41.8 M	41.8 M	41.8 M	41.8 M	55.7 M	55.7 M	55.7 M	55.7 M	-6.73 M	-6.73 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	12.9 M	17.6 M	20 M	22.7 M	27.5 M	31.9 M	35.9 M	42.5 M	56.2 M	62.8 M	76.2 M	84.9 M	90.8 M	96.4 M	101 M	41.8 M	41.8 M	41.8 M	41.8 M	55.7 M	55.7 M	55.7 M	55.7 M	-112 M	-112 M	-103 M	-98.9 M	-96.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency